Assurgen Pharma Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 80.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 75.46 Cr
as on 26-07-2024
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.50 Cr
as on 26-07-2024
- Satisfied Charges ₹ 23.29 Cr
as on 26-07-2024
- Revenue 2.92%
(FY 2023)
- Profit 1.42%
(FY 2023)
- Ebitda 10.03%
(FY 2023)
- Net Worth 643.98%
(FY 2023)
- Total Assets 7.34%
(FY 2023)
About Assurgen Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 80.00 Cr and a paid-up capital of Rs 75.46 Cr.
The company currently has active open charges totaling ₹23.50 Cr. The company has closed loans amounting to ₹23.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Assurgen Pharma Private Limited India is Ishak Mohammed as COMPANY SECRETARY. Ravi Potluri, Dr Stark, Nagendra Kukalakunta, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232AP2013PTC090442
- Company No.
090442
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Oct 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Assurgen Pharma Private Limited offer?
Assurgen Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, API (Active Pharmaceutical Ingredients), Blood System and Cardiovascular API.
Who are the key members and board of directors at Assurgen Pharma?
Executive Team (2)
NK
Nagendra Kukalakunta
Managing DirectorAppointment Date: 10-Oct-2013
Status: Current
IM
Ishak Mohammed Company SecretaryAppointment Date: 17-Mar-2022
Status: Current
Board Members(5)
Financial Performance and Corporate Structure Insights of Assurgen Pharma.
Assurgen Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.92% increase. The company also saw a slight improvement in profitability, with a 1.42% increase in profit. The company's net worth Soared by an impressive increase of 643.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assurgen Pharma?
In 2023, Assurgen Pharma had a promoter holding of 90.91% and a public holding of 9.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
21 years 6 days Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Oct 2021 | ₹23.50 Cr | Open |
Others Creation Date: 28 Jan 2019 | ₹8.00 M | Satisfied |
Others Creation Date: 05 Aug 2017 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Assurgen Pharma?
Assurgen Pharma has a workforce of 135 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jun 15, 2022, Assurgen Pharma has raised a total of ₹ 77.61 Cr, with the most recent deal valued at ₹ 12.98 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
